The role of osteopontin in kidney diseases

被引:92
作者
Kaleta, Beata [1 ]
机构
[1] Med Univ Warsaw, Inst Transplantat, Dept Clin Immunol, 59 Nowogrodzka St, PL-02006 Warsaw, Poland
关键词
Kidney; Kidney disease; Marker; Osteopontin; CALCIUM-OXALATE CRYSTALS; RENAL-CELL CARCINOMA; DIABETIC-NEPHROPATHY; BONE SIALOPROTEIN; MEMBRANOUS NEPHROPATHY; INTERSTITIAL INFLAMMATION; MACROPHAGE INFILTRATION; ANGIOTENSIN-II; MESSENGER-RNA; UP-REGULATION;
D O I
10.1007/s00011-018-1200-5
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
BackgroundOsteopontin (OPN) is a pleiotropic glycoprotein expressed in various cell types in animals and in humans, including bone, immune, smooth muscle, epithelial and endothelial cells. Moreover, OPN is found in kidneys (in the thick ascending limbs of the loop of Henle and in distal nephrons) and urine. The protein plays an important role in mineralization and bone resorption. In addition, OPN is involved in the regulation of immunity and inflammation, angiogenesis and apoptosis. It was demonstrated that OPN and some OPN gene polymorphic variants are associated with the pathogenesis and progression of multiple disorders, such as cancer, autoimmune, neurodegenerative and cardiovascular diseases. Moreover, recent studies suggested that OPN is associated with the pathogenesis of renal failure.MethodsIn this review, I briefly discussed the role of OPN and its gene polymorphisms in kidney physiology, as well as in various kidney diseases.Findings and ConclusionMost studies reported that OPN expression is elevated in urolithiasis, and also in acute and chronic kidney diseases, and in renal allograft dysfunction. Moreover, it was demonstrated that polymorphic variants of the OPN gene may be associated with renal failure. However, some reports suggested that OPN is essential for tubulogenesis, and that it inhibits calcium oxalate crystal formation and retention, nitric oxide synthesis, cell apoptosis and promotes cell regeneration.Thus, further studies are required to fully understand the role of OPN in kidney physiology and pathology. Eventually, these studies may result in the identification of OPN as a valuable marker for renal dysfunction prognosis and treatment.
引用
收藏
页码:93 / 102
页数:10
相关论文
共 117 条
[1]  
Abbate M, 1998, J AM SOC NEPHROL, V9, P1213
[2]   Kidney transplantation as primary therapy for end-stage renal disease:: A National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQI™) conference [J].
Abecassis, Michael ;
Bartlett, Stephen T. ;
Collins, Allan J. ;
Davis, Connie L. ;
Delmonico, Francis L. ;
Friedewald, John J. ;
Hays, Rebecca ;
Howard, Andrew ;
Jones, Edward ;
Leichtman, Alan B. ;
Merion, Robert M. ;
Metzger, Robert A. ;
Pradel, Francoise ;
Schweitzer, Eugene J. ;
Velez, Ruben L. ;
Gaston, Robert S. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (02) :471-480
[3]  
Afify MF., 2009, OPEN AUTOIMMUN J, V1, P59
[4]   Osteopontin expression in acute renal allograft rejection [J].
Alchi, B ;
Nishi, S ;
Kondo, D ;
Kaneko, Y ;
Matsuki, A ;
Imai, N ;
Ueno, M ;
Iguchi, S ;
Sakatsume, M ;
Narita, I ;
Yamamoto, T ;
Gejyo, F .
KIDNEY INTERNATIONAL, 2005, 67 (03) :886-896
[5]   Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity [J].
Ashkar, S ;
Weber, GF ;
Panoutsakopoulou, V ;
Sanchirico, ME ;
Jansson, M ;
Zawaideh, S ;
Rittling, SR ;
Denhardt, DT ;
Glimcher, MJ ;
Cantor, H .
SCIENCE, 2000, 287 (5454) :860-864
[6]   Contribution of human uropontin to inhibition of calcium oxalate crystallization [J].
Asplin, JR ;
Arsenault, D ;
Parks, JH ;
Coe, FL ;
Hoyer, JR .
KIDNEY INTERNATIONAL, 1998, 53 (01) :194-199
[7]   Molecular and Cellular Mechanisms for Proteinuria in Minimal Change Disease [J].
Bertelli, Roberta ;
Bonanni, Alice ;
Caridi, Gianluca ;
Canepa, Alberto ;
Ghiggeri, G. M. .
FRONTIERS IN MEDICINE, 2018, 5
[8]   THE ROLE OF ETA-1/OSTEOPONTIN IN THE PATHOGENESIS OF IMMUNOLOGICAL DISORDERS [J].
CANTOR, H .
OSTEOPONTIN: ROLE IN CELL SIGNALLING AND ADHESION, 1995, 760 :143-150
[9]   The Role of Osteopontin in Neurodegenerative Diseases [J].
Carecchio, Miryam ;
Comi, Cristoforo .
JOURNAL OF ALZHEIMERS DISEASE, 2011, 25 (02) :179-185
[10]   Membranous nephropathy: integrating basic science into improved clinical management [J].
Cattran, Daniel C. ;
Brenchley, Paul E. .
KIDNEY INTERNATIONAL, 2017, 91 (03) :566-574